Skip to Content

ZA64 25 mg (Topiramate (Sprinkle) 25 mg)

Pill with imprint ZA64 25 mg is White, Capsule-shape and has been identified as Topiramate (Sprinkle) 25 mg. It is supplied by Zydus Pharmaceuticals.

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA64 25 mg

Topiramate (sprinkle) 25 mg ZA64 25 mg
Topiramate (sprinkle) 25 mg ZA64 25 mg
Topiramate (sprinkle) 25 mg ZA64 25 mg
Topiramate (sprinkle) 25 mg ZA64 25 mg

Topiramate (Sprinkle)

Imprint
ZA64 25 mg
Strength
25 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals
National Drug Code (NDC)
68382-0005
Inactive Ingredients
cellulose acetate, hypromelloses, gelatin, povidone, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.